falling knife.....this is unbelievable to me.....I would have thought it would hold in the $3s.....sure doesn't look like it, but we will see......this is a solid company, and had a little negative cash flow last quarter around $100k so not sure why this is dumping like this, but.......worst revenue quarter last quarter I suppose does not bode well for Q4 results.....it will be interesting to see what the new guy has in store for this place....wondering if there will be some cost cutting going on or not.....
well....I don't think this should have been surprising at all......they more or less stated this was gonna be the case as guidance....I also think that is what cost Markin his job.....this was unacceptable tot he BOD so a change had to be made....we will see what the new guy can do to create value here.....lets face it....he does have the advantage of starting with bad numbers so to eclipse them shouldn't be that hard.....I think 2013 is done...meaning, there is nothing they can do to save the year....I was surprised to see this up today on the CC news, but whatever,.....perhaps some shorts covering...then again...why? especially if there might be more downside here.....I got out at 4.73....and should have left when it was in the $5 to $6 range but I sometimes hang on too long to these kinds of things....I was lucky to find another option that I felt very very very comfortable with..... :D
he did okay here for a while, but just wasn't able to deliver sadly....I can understand why some shareholders feel this way.......its not always easy to get things to go your way....its a risk and Markin must have played his final card, otherwise, I don't think the board would have gotten rid of him.......oh well....lets see what the new guy can do.....as expected, not a very good quarter, but definitely was left with some to build from and to..... :D
Just got done listening to the conf. call. Not very encouraging. To late for me to sell. In the very first FDA comments they wanted a new predicate for the study. But the management took the approach of trying to convince the FDA otherwise. A new study will cost money and time. Sounded like the new interim CEO will end this effort. Maybe the slow bookings was a result of vendors finding out about VSCP's personal medicine ambitions. One thing I still don't understand is that they have been talking about increased booking since late last year. But to date the revenue is still declining. I would have thought that most bookings would have started turning into revenue in 6 months. It is looking more like 6 quarters if it happens at all. Looks more and more each day that this investment will remain a dog. I don't see any light at the end of this tunnel. How did you like CEO's answer of him buying stock when he thinks it is "worthy investment". Right now it is not. "gochas" you might be right. If the revenue don't increase next year VS is Toast.
It's not fair to Jeff to say he did not care about shareholder value since a large chunk of his compensation is tie to the stock price, unless, of course, the board allow him to cash out in exchange of his resignation.
Innovative technology? They're still selling the same thing they're selling ten years ago. IMO, the CSO and CTO are the ones that should go. The company may just be profitable from saving of these two positions.
btw....I took my proceeds here and went over to NEO....in case anyone is curious....not suggesting anyone do the same, but I think they are the anti-thesis of VSCP and are going the opposite directions regarding market capitalization......so hard for me to do an about face right now as I like my chances there better than here for.....now.....this is trading like as if they are going to have some liquidity issues imho.....hope I'm totally wrong, but....lets see what Q3 results show and how cash flow goes there.......I think that will be the tale of the tape imho.....:D
well....should be higher than .35 cents pre-split value thats for sure.....I don't know what to say about this....it has been beyond disappointing imho.....and wondering what happened here with the leadership......they just couldn't get r dun imho......or they over promised and obviously didn't deliver........I still like the company, but at this point....not sure what to make of it....will be interesting to see what they have to say about things going forward from here at the CC....from what I recall....Markin said not to expect much in Q4 either.....so, lets see what the new guy has to say about the direction for 2014.....again...I'm out at $4.73 and hold no position long or short.....re-entry at this point looks tempting, but.....hate to take a chance and see it dip below $3.......it may not, but still....long term I think this can still do well so perhaps I should get to greedy and take the plunge back in....we will see...I going to wait....I think there will be more downside after earning are released because I think that is why Markin was sent packing......Q3 results and lack of anything going forward that looked promising imho......as I believe the FDA thing is DEAD imho.....and Markin was putting his career there behind that imho.....but again...who knows....but it can't be good that a CFO and CEO resign or retired or whatever.....:D
Reference: "....Mr. Markin said, "I have greatly enjoyed my tenure at VirtualScopics and am proud of our accomplishments. We've laid a strong foundation for success as evidenced by growth in revenue, margin, cash and new bookings. I wish Mostafa, the Board, and our employees well as they steward VirtualScopics into a successful and profitable future."..."
Jeff really did not care that much about shareholder value. He didn't even mention shareholders in his last speech. There is still a good possibility, the new CEO will pick this up and start running with additional contracts. They have innovative technology and can't beat companies that don't have innovative technology--Something was wrong! My opinion, Jeff and Molly wasn't doing their job. Right now, this company ought to be $20 dollars a share.
ummmm.....wow.....I would like to think this will hold in the 3s....buttttttttttttt......not so sure anymore.....I do still think the company is fairly stable and this is all just an over reaction to recent events....however. we will see what Q3 numbers look like.....we were warned its not going to look like Q2..... :D
well...perhaps he readies it for a sale.....which I would assume the shareholders would have to be agreeable to.....and I don't think the major holders want to "give' it away...... :D
no disagreement with you birds on the potential....I just saw another opportunity elsewhere that I thought had more short term promise than here....so far, I've been right about it....so far.....thats not to say things won't turn around here, but based on the last CC comments, to me, its fairly obvious they weren't going to knock anyone's socks off the last two quarters of 2013......I think a good re-entry point here might be in early or late Q1.....we will see....I do think it is headed for sub $4....and hope it stabilizes there somewhere for most longs here.....the R/S and the lack and apparent dismissal of the CFO and CEO was not encouraging, however, when new blood is brought in, its brought in for a reason.....and could pump new life into the company....but in the meantime, history has already been paved so the new peeps will have to live with the numbers......and of course the effects y..of market perception towards valuation sadly......not to mention perhaps unscrupulous trading trying to take advantage here....... :D
Mostafa Analoui is ex-pfizer and not a business builder. The interim CEO is a PE guy who knows nothing about the imaging space. I contend that VS will not be a public company very much longer and unfortunately they will not receive a premium when they sell it because of the lack of backlog and EBITDA.
Sentiment: Strong Sell
It is possible the new CEO will be able to get the personalized medine application approved by the FDA. Either they have a patentable application or not. It seems to me the UofR, GE, Tocqueville, Vanguard, and others listed in Yahoo Finance would have sold all their shares if they felt it wouldn't be advantageous to continue holding VSCP shares. Other companies and organizations can use VSCP' technology i.e., the space exploration program, military and police applications, etc. Then, perhaps the new CEO will get the company sold to Merck, GE, ICLR, or PPD. One of these companies can nurse VSCP back to health to at least $20 dollars a share.
Sentiment: Strong Buy
"perhaps I did make the right decision for a change in getting out"
Maybe the new CEO will turn this around and maybe a good time to get back in.
Sentiment: Strong Buy
Thanks Mr. Dr. Analoui and board. This company should be at least $15 to $20 dollars or more a share. Why is it not? It looks like the CFO and CEO wasn't doing their jobs. This is the irony! A company that assists other companies in acquiring FDA compliance for their drugs cannot get compliance for their product (the personalized medicine application)--something was wrong with that.
I hope the new CEO will get FDA 501 approval of VSCP's personalized medicine application and get Merck Gobal Innovation Fund back to the table in supporting VSCP. First, this application needs to be approved by the FDA, second, get Merck back on the project, third, major hospital facilities adopt's the techology to save money and lives, insurance companies will follow in order to save money and lives. Fourth, this should bring our PPS back to where it should be $20 a share. If yahoo is correct, it has ICLR at 2.66 Billion market cap in a 899 million industry. We have a market cap of only 12 million dollar in market cap. VSCP has a long way to go or growth. I feel VSCP's innovation will put us on the map if we can get them off the ground.
In any case, Jeff Markin made a big mistake when he took 3 mil from Merck and did not include them in the development and progress of their projects, imo. I don't know this for sure. But if I gave someone 3 mil for development I would monitor progress to ensure things were on track.
Sentiment: Strong Buy
wow.....didn't see that coming, but then again....I did get out, but I thought it was just going to be a delay in this turning around....I suppose it still could, but if what you say is true about the new guy....then they will be shopping this around to bigger fish.....wonder what it would sell for.....I would assume the new guy will be making a lot of short term cuts to dress it up some...but whatever, maybe the new guy will be a turnaround expert.....I do get the feeling the next two quarters are not going to be good at all imho since Markin has been let go.....perhaps I did make the right decision for a change in getting out.....:D
so far, but its early, I think I've made the right decision...so far.....but as we all know, things can change in heartbeat on these kinds of stocks....especially this one, considering that at the split, there are so many LESS shares.....however, what does that mean??? It does allow for more volatility up or down...and with UofR holding the cards at the moment...I have to wonder exactly where they will decide to sell...will it be at $6??? or will they allow it to go higher...whatever, at this point, unless VSCP comes up with some good news that drive future revenue potential, I could see the share price here continue to languish...and of course, they didn't say anything in the last CC that would suggest the last two quarters are going to be any great shakes.....I'm hoping they have some good news after the year end in Q1 2014.....sadly, I think the market will not be kind when they report Q3 earnings results even though they have already said to not expect another quarter like Q2.....I really didn't want to sell here, but it just became a choice of either sitting on it or playing another option I thought was more attractive...and YES...I hate selling at such a low price to be sure....as I agree that it is near the bottom, but depends on your perspective sadly....52 week low is $3.80?....so, not so sure it won't retest that at some point between now and Q1 2014.....thanx for your thoughts and GL2U....depending on my other option, I will be back here though...I still like this place and its potential no doubt, and I do think its worth waiting out......patience, as always is the key here, and I'm hoping I didn't make a bad decision on this at this time.... :D